Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate efficacy and safety of R-GemOx Versus R-miniCHOP
as first-line treatment of elderly patients with Diffuse large B cell lymphoma
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University